© 2003 American Public Health Association
C. H. Brouse, C. E. Basch, and R. L. Wolf are with the Dept of Health and Behavior Studies, Teachers College, Columbia University, New York, NY. C. E. Basch is also with the Herbert Irving Comprehensive Cancer Center, New York, NY. C. Shmukler is with the Disease Management and Wellness Program, New York, NY. A. I. Neugut is with the Herbert Irving Comprehensive Cancer Center and the Dept of Medicine, Columbia University College of Physicians and Surgeons, New York, NY. S. Shea is with the Dept of Medicine, Columbia University College of Physicians and Surgeons. Correspondence: Requests for reprints should be sent to Charles E. Basch, PhD, 525 W 120 St, Box 114, Department of Health and Behavior Studies, Teachers College, Columbia University, New York, NY 10027 (e-mail: ceb35{at}columbia.edu).
Colorectal cancer is the second leading cause of cancer death in the United States.1 Appropriate screening can reduce incidence of and mortality from colorectal cancer.25 The US Preventive Services Task Force recommends that all average-risk individuals aged 50 years and older receive colorectal cancer screening.6 The American Cancer Society recommends several acceptable approaches to screening, including an annual 3-card home fecal occult blood test.7 The Healthy People 2010 objective is to increase the proportion of people aged 50 and older who have received a fecal occult blood test within the preceding 2 years to at least 50%.8 Lack of knowledge, confidence, and skills; negative attitudes toward the tests themselves; fear of the consequences of screening; and inadequate social support all have been suggested as possible barriers to colorectal cancer screening,9 whereas positive attitudes toward colorectal cancer screening and physician encouragement have been associated with receipt of a fecal occult blood test with a home stool kit.10 Despite these studies, gaps remain in what is known about barriers to successful interventions to increase colorectal cancer screening, particularly in minority populations.11,12 This study is based on the assumption that identification and definition of barriers to colorectal cancer screening in low-income, underserved minority populations can help guide the development of effective interventions.
The Healthy Colon Project is a randomized controlled trial designed to test whether a telephone-based health intervention will increase fecal occult blood test screening rates for colorectal cancer among active members and their dependents in a health care workers union.13 More than 80% of the union members are from lower-income occupations, including food service workers, custodians, laboratory technicians, and clerks. The approximate racial/ethnic composition is 35% Black non-Hispanic, 45% Hispanic, 15% White non-Hispanic, and 5% Asian/Pacific Islander. The fecal occult blood test is 100% reimbursable for all union members. In the year 2000, a pilot study was conducted with 42 participants, aged 53 to 80 years, who had not had colorectal cancer screening within the preceding 2 years and who agreed to pilot test the telephone-based health education intervention. An intensive qualitative analysis of information obtained from 8 of these 42 pilot subjects was performed to improve understanding about barriers to successful intervention implementation.14 These 8 cases were selected because they illustrate particular barriers. The intervention involved multiple telephone conversations between the health educator and each participant over a 2-month period. The initial call followed a loosely structured outline and contained selected factual information, tailored to the needs of each participant (e.g., stage of readiness to change, colorectal cancer knowledge, screening test preference, access to resources, skills, social support), as well as other individual characteristics (e.g., talkativeness). Several health behavior and health education theories guided these interactions.1518 If a verbal commitment to complete a colorectal cancer screening test was made, follow-up contacts reinforced this commitment and addressed barriers. If a verbal commitment was not offered, subsequent calls addressed barriers to making such a commitment.
Data Collection and Analysis
The 8 participants (6 women and 2 men) ranged in age from 54 to 72 years (mean = 61.4). Five participants characterized their race/ethnicity as Hispanic, 2 as Black or African American, and 1 as White. Descriptions of the participant interactions with the health educator are presented to illustrate the most common barriers encountered (Table 1
Limitations include (1) the small sample, (2) data based on self-report,19,20 and (3) data based on only the perspective of the participant, not the perspective of the primary care provider. Despite these limitations, these results provide new information about barriers to colorectal cancer screening in predominantly minority populations. A previously unreported finding in several of the interviews was that participants encountered obstacles in obtaining the fecal occult blood test from their physicians. To date, little is known about barriers to participation by physicians in colorectal cancer screening with the home stool kit.21,22 We speculate that the barriers may include (1) lack of office personnel or systems to track requests, to mail fecal occult blood test kits to patients homes, and to follow up once the kit is returned; (2) concerns about patient compliance; (3) lack of knowledge about or belief in the effectiveness of fecal occult blood testbased colorectal cancer screening or the appropriate age range for colorectal cancer screening; and (4) possibly lack of reimbursement of physician time related to the test administration and tracking when done outside an office visit, despite the reimbursability of the fecal occult blood test itself. These possibilities need further exploration. We found that the informal and unstructured educational approach used to promote patient participation in colorectal cancer screening allowed for maximum tailoring of the intervention to each individual. Tailoring permitted us to address a variety of needs for different participants. In some participants, tailoring focused on enhancing motivation (e.g., by increasing knowledge), whereas in others, emphasis was placed on addressing deficits in skills or self-efficacy through coaching and role-playing. In others, communications were tailored to provide social and emotional support, including dealing with fear and denial. We also found that even when individuals were motivated and initiated action, environmental barriers related to the availability or accessibility of the fecal occult blood test could significantly hinder their efforts to obtain colorectal cancer screening. One of the greatest public health challenges we currently face is reducing disparities in health between social groups in the United States. Progress in reducing disparities in morbidity and mortality can be addressed by promoting preventive practices such as screening in underserved populations. We currently have little understanding of barriers to colorectal cancer screening in such populations and how they can be ameliorated. This study is intended to be one small but meaningful step in this direction by identifying issues that warrant further investigation.
This research was supported by grants R01 CA81932, K05 CA89155, and P30 CA13696 24 from the National Cancer Institute. We thank the technical and support staffs at Teachers College and Columbia Universitys Herbert Irving Comprehensive Cancer Center for their ongoing contributions to this project. Our appreciation goes to the study participants for their time and participation. Human Participant Protection The institutional review boards at Teachers College and Columbia-Presbyterian Medical Center approved the study protocol. Informed consent was obtained from each participant. Initials of the participants have been changed to ensure confidentiality.
Contributors C. H. Brouse collected and analyzed the data. C. E. Basch and R. L. Wolf planned the study, dealt with methodological issues of data collection and analysis. S. Shea, A. I. Neugut and C. Schmuckler assisted with planning the study, dealt with medical issues related to the implementation of the study. All authors contributed to writing the brief. Accepted for publication November 25, 2002.
1. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin.2003;53:526. 2. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomized study of screening for colorectal cancer with faecal-occult-blood test. Lancet.1996;348(9040):14671471.[Web of Science][Medline] 3. Hardcastle JD, Chamberlain JO, Robinson MHE, et al. Randomized controlled trial of faecal-occult blood screening for colorectal cancer. Lancet.1996;348(9040):14721477.[Web of Science][Medline]
4. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med.1993;328:13651371.
5. Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:16031607. 6. Pignone M, Rich M, Teutsch SM, Berg AO, Lohr KN. Screening for colorectal cancer in adults at average risk: a summary of evidence for the U.S. Preventative Services Task Force. Ann Intern Med.2002;137:E132E141.
7. Smith RA, von Eschenbach AC, Wender R (for the ACS Prostate Cancer Advisory Committee), et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. CA Cancer J Clin.2001;51(1):3875. 8. Healthy People 2010: Understanding and Improving Health. Washington, DC: US Dept of Health and Human Services; 2001. Also available at: http://web.health.gov/healthypeople/document. Accessed July 20, 2001. 9. Beeker C, Kraft JM, Southwell BG, Jorgensen CM. Colorectal cancer screening in older men and women: qualitative research findings and implications for intervention. J Community Health.2000;25:263278.[Web of Science][Medline] 10. Mandelson MT, Curry SJ, Anderson LA, et al. Colorectal cancer screening participation by older women. Am J Prev Med.2000;19:149154.[Web of Science][Medline]
11. Vernon SW. Participation in colorectal cancer screening: a review. J Natl Cancer Inst. 1997;89:14061422. 12. Jepson R, Clegg A, Forbes C, Lewis R, Sowden A, Kleijnen J. The determinants of screening uptake and interventions for increasing uptake: a systematic review. Health Technol Assess. 2000;4(14):1413.[Medline] 13. Wolf RL, Zybert P, Brouse CH, et al. Knowledge, beliefs, and barriers relevant to colorectal cancer screening in a urban population: a pilot study. Fam Community Health.2001;24(3):3447.[Web of Science][Medline] 14. Basch CE. Focus group interview: an underutilized research technique for improving theory and practice in health education. Health Educ Q.1987;14:411448.[Web of Science][Medline] 15. Prochaska JO, Redding CA, Evers KE. The transtheoretical model and stages of change. In: Glanz K, Lewis FM, Rimer BK, eds. Health Behavior and Health Education: Theory, Research, and Practice. 2nd ed. San Francisco, Calif: Jossey-Bass Inc Publishing Co; 1997:99120. 16. Rimer BK. Models of individual health behavior. In: Glanz K, Lewis FM, Rimer BK, eds. Health Behavior and Health Education: Theory, Research, and Practice. 2nd ed. San Francisco, Calif: Jossey-Bass Inc Publishing Co; 1997:3759. 17. Green LW, Kreuter MW. Health Promotion Planning: An Educational and Environmental Approach. 2nd ed. Mountain View, Calif: Mayfield Publishing Co; 1991. 18. Baranowski T, Perry CL, Parcel GS. How individuals, environments, and health behavior interact: social cognitive theory. In: Glanz K, Lewis FM, Rimer BK, eds. Health Behavior and Health Education: Theory, Research, and Practice. 2nd ed. San Francisco, Calif: Jossey-Bass Inc Publishing Co; 1997:153178.
19. Mandelson MT, LaCroix AZ, Anderson LA, Nadel MR, Lee NC. Comparison of self-reported fecal occult blood testing with automated laboratory records among older women in a health maintenance organization. Am J Epidemiol.1999;150:617621. 20. Hiatt RA, Perez-Stable EJ, Quesenberry C Jr, Sabogal F, Otero-Sabogal R, McPhee SJ. Agreement between self-reported early cancer detection practices and medical audits among Hispanic and non-Hispanic white health plan members in northern California. Prev Med.1995;24:278285.[Web of Science][Medline] 21. Sharma VK, Corder FA, Raufman JP, Sharma P, Fennerty MB, Howden CW. Survey of internal medicine residents use of the fecal occult blood test and their understanding of colorectal cancer screening and surveillance. Am J Gastroenterol.2000;95:20682073.[Web of Science][Medline] 22. Schroy PC, Geller AC, Crosier Wood M, et al. Utilization of colorectal cancer screening tests: a 1997 survey of Massachusetts internists. Prev Med.2001;33:381391.[Web of Science][Medline] This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||